In addition to its role as a gut hormone, cholecystokinin (CCK) is a widespread and potent neurotransmitter. Its biosynthesis requires endoproteolytic cleavage of proCCK at several mono-and dibasic sites by subtilisin-like prohormone convertases (PCs). Of these, PC1 and PC2 are specific for neuroendocrine cells. We have now examined the role of PC2 and its binding protein, 7B2, in the neuronal processing of proCCK by measurement of precursor, processing-intermediates and bioactive end-products in brain extracts from PC2-and 7B2-null mice and from corresponding controls. PC2-null mice displayed a nine-fold increase of cerebral proCCK concentrations, and a two-fold increase in the concentrations of the processing-intermediate, glycine-extended CCK, whereas the concentrations of transmitter-active (i.e. a-amidated and O-sulfated) CCK peptides were reduced (61%). Chromatography showed that O-sulfated CCK-8 still is the predominant transmitter-active CCK in PC2-null brains, but that the fraction of intermediate-sized CCK-peptides (CCK-58, -33 and -22) was eight-fold increased. 7B2-null brains displayed a similar pattern but with less pronounced precursor accumulation. In contrast with the cerebral changes, PC2 deficiency was without effect on proCCK synthesis and processing in intestinal endocrine cells, whereas 7B2 deficiency halved the concentration of bioactive CCK in the intestine. The results show that PC2 plays a major neuron-specific role in the processing of proCCK.
Cholecystokinin (CCK) is the most abundant peptide transmitter in the mammalian brain (Rehfeld 1978b; Larsson and Rehfeld 1979; Crawley 1985) . Accordingly, CCK defects have been associated with major neuropsychiatric diseases such as anxiety, schizophrenia and satiety disorders (Gibbs et al. 1973; Hö kfelt et al. 1980; Ferrier et al. 1983; Bradwejn and de Montigny 1984; Bradwejn et al. 1990; Geracioti et al. 1992; Rehfeld 1992) . CCK is also synthesized outside the central and peripheral nervous system, primarily in the endocrine I-cells of the small intestine. But still cerebral neurons synthesize most of the CCK in the mammalian body (Rehfeld 1978b) . Mammalian proCCK harbor several basic cleavage sites of which one dibasic (R 85 -R 86 ) and four monobasic (R 25 , R 50 , K 61 , R 75 ) are known to be cleaved (Fig. 1) . The precursor processing is tissue-specific in the sense that the pattern of bioactive (i.e. carboxyamidated and O-sulfated) forms varies. Hence, while intestinal CCK is a mixture of CCK-5, CCK-8, CCK-22, CCK-33, CCK-58 and CCK-83 of which CCK-33 and -22 predominate in plasma (Cantor and Rehfeld 1987; Rehfeld et al. 2001) , the predominant neuronal CCK is the sulfated octapeptide, as the larger forms are present only in trace amounts in the normal brain (Dockray et al. 1978; Rehfeld 1978b; Larsson and Rehfeld 1979; Marley et al. 1984; Rehfeld 1985; Rehfeld and Hansen 1986) .
The elaborate post-translational processing of proCCK requires several processing enzymes (Fig. 1) . While the involvement of tyrosyl sulfotransferases, carboxypeptidase E and the amidation enzyme complex (PAM) is well established, the roles of PC1, PC2 and other prohormone convertases (PCs) remain to be defined. Mammals express seven PCs, of which PC1 and PC2 are assumed to be responsible for most of the endoproteolytic processing of neuroendocrine proproteins (for reviews, see Rouillé et al. 1995; Seidah and Chrétien 1997; Steiner 1998; Mü ller and Lindberg 2000) . The PC cleavages typically occur at dibasic sites although both PC1 and PC2 have been shown to be capable of single basic cleavage. There are three dibasic sites in proCCK (R 21 -R 22 , R 50 -K 51 and R 85 -R 86 ), but only the C-terminal R 85 -R 86 site is processed as such, although cleavage also occurs after R 50 in the middle site, but as if it was monobasic (Fig. 1) . Processing of the R 85 -R 86 site determines the availability of the glycine-extended precursor for a-amidation, and hence establishes the amount of CCK peptides which can become ligands for the CCK-A and CCK-B receptors. Subsequent cleavage of the monobasic sites (R 25 , R 50 , K 61 , and R 75 ) then determines then the length of the N-terminal extensions, and hence whether the carboxyamidated and O-sulfated fragments become CCK-8, In order to determine the role of PC2, we have now examined the cerebral and intestinal processing of proCCK in PC2-and 7B2-null mice. 7B2 is a neuroendocrine protein, that acts as a molecular escort necessary for PC2 activity Martens et al. 1994; Zhu and Lindberg 1995) . An intriguing aspect of the problem studied here is that only one of three dibasic sites and four of nine monobasic sites in proCCK are cleaved (Fig. 1) . Therefore proCCK may be an instructive substrate for examination of the relative roles of prohormone convertases in peptide biosynthesis.
CCK nomenclature
Murine proCCK is a protein of 95 amino acid residues (Fig. 1) . The earliest post-translational modification of proCCK appears to be O-sulfation of Y 77 , Y 91 and Y 94 by sulfotransferases in the trans-Golgi network of CCKneurons. Sequence 83-86 (-FGRR-) constitutes the amidation Fig. 1 Diagrammatic presentation of the co-and post-translational modification of preproCCK. Activation of the CCK amidation site (-FGRR-, sequence 83-86 of proCCK) occurs via a series of carboxyterminal cleavages and modifications. Endoproteolytic cleavage by PCs produces the carboxypeptidase E substrate (-FGR-). Carboxypeptidase E then acts in synaptic vesicles to remove the C-terminal arginyl residue yielding glycine-extended CCK (-FG-). Carboxyamidation of glycine-extended CCK by a-amidating monoxygenase results in the production of bioactive CCK (-F-NH 2 ). Concomitant N-terminal cleavages by PCs produces bioactive CCKs of varying size. A library of sequence-specific antibodies was used in combination with in vitro endoprotease treatments to measure bioactive CCK and precursor peptides as described in the text.
site, which requires processing by prohormone convertases, carboxypeptidase E, and the amidation enzyme complex to release bioactive carboxyamidated CCK peptides. The largest bioactive form is CCK-83, which corresponds to the carboxyamidated sequence 1-83 of proCCK (Eberlein et al. 1992 ). This sequence is cleaved at least at four monobasic sites to release CCK-58, -33, -22 and -8, all of which have the same C-terminal heptapeptide amide sequence MGWMDFamide], which is also the minimal epitope necessary for CCK-A receptor binding. Binding to CCK-A receptors requires that the tyrosyl residue of the heptapeptide amide is O-sulfated, whereas CCK-B receptors do not discriminate neither sulfated from non-sulfated CCKpeptides nor CCK from gastrin peptides (for review, see Wank 1995) . In mammals, neuronal CCK is predominantly CCK-8, whereas endocrine CCK is a mixture of CCK-58, CCK-33, CCK-22, CCK-8 and CCK-5 (Rehfeld 1985; Rehfeld et al. 2001) .
In the study of the cellular proCCK processing to different molecular forms of CCK, it is essential to know that maximal tissue extraction of the small molecular form (CCK-22, CCK-8 and CCK-5) requires neutral pH, whereas the intermediate sized CCKs (CCK-58, CCK-39 and CCK-33) preferentially are extracted at acidic pH (Rehfeld and Hansen 1986 ). The precise explanation for this discrepancy is unknown; but it is generally believed to reflect differences in the net charges of the intermediate sized versus the small sized CCKs.
Experimental procedures
Mice Both PC2 and 7B2 knockout (-/-) and corresponding wild-type (+/+) mice were generated by intercrossing heterozygotes and genotyping the offspring. The PC2 knockouts (-/-) (Furuta et al. 1997) and corresponding control mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA), whereas the 7B2 knockouts (-/-) (Westphal et al. 1999) and controls (both Sv129 mice) were generated in LSUHSC (New Orleans, LA, USA), from where relevant tissues (brain and small intestine) were sent to Copenhagen. The mice were housed on a 12-h light/dark cycle and freely fed. All experiments were approved by the Animal Ethics committees of the local institutions.
Tissue isolation and extraction
Groups of five to eight mice between 2 and 6 months of age were killed by CO 2 inhalation. The whole brain and small intestinal (jejunal) tissue was rapidly dissected and frozen on dry ice. The tissue was gently cleaned in phosphate buffered saline on ice before freezing, and otherwise kept at ) 80°C until analysis. The brain and jejunal tissue samples from 7B2 knockout and corresponding wild type mice were sent frozen by courier mail from New Orleans on abundant dry ice. Extraction of all tissues in both the 7B2 and PC2 series were performed at Rigshospitalet (Copenhagen) using the same procedure as previously described (Lacourse et al. 1998) . Briefly, frozen tissues were boiled in water (1 mL/mg) for 20 min, homogenized (polytron) and centrifuged for 30 min at 15 000 g. The supernatants were removed and the pellets re-extracted in 0.5 M CH 3 COOH (1 mL/mg), rehomogenized, incubated at room temperature for 30 min and centrifuged. The neutral water and acid supernatants were stored separately at )20°C until radioimmunoassay (RIA) analysis.
Chromatography
One or two milliliters of either neutral water or acetic acid extracts were applied to Sephadex G-50 superfine columns (10 · 1000 mm), which were eluted at 4°C with 0.02 M barbital buffer, pH 8.4, containing 0.1% bovine serum albumin. Fractions of 1.0 mL were collected at a rate of 4.0 mL/h. The columns were calibrated with [ NaCl (total volume). The elutions were monitored with sequence-specific RIAs using antisera numbers 92128, 3208 and 2609 as described below. Four independent water or acid extracts from each of the four groups of mice (PC2 knockout, 7B2 knockout and corresponding controls) were subjected to gel chromatography.
Radioimmunoassays
A library of sequence-specific antibodies against proCCK and its products was used to measure proCCK, processing intermediates and the different carboxyamidated forms of CCK (Fig. 1) . The sum of carboxyamidated and tyrosyl O-sulfated CCK peptides was measured using the CCK-specific antiserum number 92128, with Bolton-Hunter labelled [ 125 I]CCK-8 as tracer and CCK-8 as standard (Rehfeld 1998) . Antibody number 92128 binds all the carboxyamidated and O-sulfated forms of CCK with equimolar affinity irrespective of size. It does not bind CCK-5 and has no cross-reactivity with homologous gastrin peptides. The sum of sulfated and non-sulfated carboxyamidated CCK peptides, including CCK-5, were measured in parallel using antibody number 2609 (Rehfeld 1978a) . Glycine-extended processing-intermediates of CCK were measured using antiserum number 3208 with [ 125 I]glycine-extended CCK-8 as tracer and glycine-extended CCK-8 as standard. Glycine-arginine-extended intermediate precursors were measured using antiserum number 3208 following enzymatic pretreatment with only carboxypeptidase B (CPB). In order to measure all CCK-precursor forms, samples were pretreated with both trypsin and CPB followed by RIA using antiserum number 3208, as described previously (Hilsted and Rehfeld 1986) . CPB mimics the effect of CPE, while trypsin mimics the effects of prohormone convertases.
Statistics
All peptide concentrations are expressed in pmol/g tissue as means ± SEM. Statistical analysis was carried out using an unpaired t-test. Only p-values < 0.05 were considered significant.
Results
As shown in Table 1 , lack of PC2 significantly changes the processing of proCCK in cerebral neurons. The total translational product (proCCK, processing-intermediates plus a-amidated endproduct) is on average increased from 161 pmol/g in wild-type brains to 230 pmol/g in knockout brains. The largest difference affects proCCK, the concentration being nearly nine-fold increased, but also the concentration of glycine-extended CCK is significantly increased. In contrast, the concentration of the transmitteractive a-amidated CCK peptides is reduced to 61% of wildtype levels. Comparison of CCK peptide concentrations in neutral and acidic extracts also reveal major effects of PC2 deficiency. Hence, as shown also in Table 1 , the fraction of proCCK products is significantly increased in the acidic extracts of PC2-null brains. For a-amidated and O-sulfated CCKs, the increase is more than five-fold (Table 1) . The acidic extracts mainly contain intermediate-sized precursor products such as CCK-58, -33 and -22 (see above). A similar pattern is seen in the brains of 7B2 knockout mice (Table 2) , although the deviations in the concentration of the individual processing parameters are smaller.
Tables 1 and 2 also reveal differences between the proCCK concentrations, for instance, of the two groups of wild-type controls. Presumably, the differences reflect the use of different strains of mice at different ages. As mentioned above, the PC2 study used C57BL/6 J:Sv129 mice, and the 7B2 study Sv129 mice. Moreover, the mice in the 7B2 study and its controls were 3 weeks younger than those in the PC2 study due to the high mortality of 7B2-null mice (Westphal et al. 1999) .
Gel chromatography of cerebral extracts showed that the far most predominant form of the transmitter-active (i.e. carboxyamidated) CCK is the sulfated octapeptide, CCK-8, both in PC2-and 7B2-null mice as well as in the control brains (Fig. 2) . However, in contrast with the control brains, which contained only traces of larger CCKs (like CCK-33, Fig. 2 ), the chromatography revealed significant amounts of CCK-83, -58, -33 and -22 also in the neutral extracts of null brains (Fig. 2) . The increased concentrations of proCCK and glycine-extended CCK in the cerebral extracts from PC2-null mice (Table 1 ) allowed chromatographical characterization. This work showed that proCCK, as defined in the present study, elutes as a large form corresponding to intact proCCK (Fig. 3) and a less abundant and smaller form corresponding to N-terminally truncated proCCK, which elutes in a position corresponding to CCK-58. Glycine-extended CCK elute in three peaks corresponding to glycine-extended CCK-83, -22 and -8 (Fig. 3) . The cerebral extracts from the control mice contained the same molecular forms of proCCK and glycine-extended CCKs, but in significantly lower concentrations (Fig. 3) . Chromatography of acidic extracts from PC2-null brains confirmed that they contain mainly intermediate-sized CCK-58, -33 and -22 (Fig. 4) . The concentration and processing pattern of proCCK and its products in the small intestine was unaffected by the lack of PC2 (Table 3 ). In contrast, the loss of 7B2 resulted in substantially lower concentrations of bioactive CCK in the intestine, i.e. 51% of the concentrations measured in the wild-type controls (Table 4) . Gel chromatography did not reveal significant differences in the molecular pattern of intestinal CCK between PC2-, and 7B2-null mice and their corresponding controls (data not shown). Neither did acidic versus neutral extracts differ between knockout and corresponding control intestines (data not shown).
Discussion
The relative contributions of the various prohormone convertases to precursor cleavages is only now beginning to be elucidated. One of the important findings of the present study is that neuronal expression and processing of proCCK is profoundly influenced by PC2. The effect, however, is unexpected and perhaps indirect. Thus, although PC2 apparently does contribute to the cleavage of the lysyl containing di-and monobasic sites of proCCK (R 50 -K 51 and K 61 ) in the late phase of the post-translational maturation, as revealed by the accumulation of intermediate-sized CCKs in both acidic and neutral extracts (Table 1, Figs 2 and 4) , substantial processing to CCK-8 still occurred. Instead, the major effect of PC2 knockout is an accumulation of unprocessed proCCK and its processing-intermediate, glycine-extended CCK, as well as a decrease in the content of the bioactive, amidated CCK-peptides in cerebral neurons. Hence, PC2 appears to be required for cleavage of the decisive R 85 -R 86 site at the C-terminus of proCCK, a site that otherwise is assumed to be processed by PC1 at an early stage of precursor processing in the regulated secretory pathway. Arguments in favor of this notion about PC1 are, that PC1 generally acts at an earlier stage than PC2 in the Fig. 2 Gel chromatography on Sephadex G-50 superfine columns of neutral water extracts from the brain of 7B2 and PC2 knockout mice (upper panels) and from corresponding wild-type control mice (WT; lower panels). The chromatographic elutions were monitored by a radioimmunoassay using antibody number 2609 (d), that binds carboxyamidated CCKs (the bioactive CCKs) irrespective of the degree of tyrosylsulfation. Extracts from four different mice in each of the four groups (7B2 and controls, PC2 and controls) were subjected to chromatography. Those shown above are characteristic of each group.
processing of prohormones (for reviews, see Rouillé et al. 1995; Mü ller and Lindberg 2000; Seidah and Chrétien 1997) and, moreover, that the identical cleavage site in the homologous precursor progastrin, is unaffected in PC2 deficiency (Rehfeld et al. 2002) . Alternatively, the loss of PC2 could indirectly affect PC1-mediated cleavages, although the mechanism for such effect is unknown. This may also represent the case with POMC (Allen et al. 2001) . The exact mechanism behind the decreased concentration of transmitter-active CCK in spite of an increased amount of the total proCCK product is unknown. So far, we have no evidence of neither increased synaptic release of amidated CCK nor of any feedback regulation of the concentration of amidated CCK on the translation of neuronal CCK mRNA.
Whatever the mechanism of PC2 may be in neurons, PC2 is apparently not required for the synthesis and processing of proCCK in the endocrine I-cells of the small intestine. Hence, the intestinal proCCK processing and the level of expression was entirely normal in the PC2-null mice. These data suggest that PC2 may not be expressed in murine intestinal I-cells in contrast to human I-cells (Scopsi et al. 1995) . Alternatively I-cells contain redundant activity of other prohormone convertases that mimicks the effect of PC2 in time and space along the secretory pathway.
The present study also included examination of knockout of the PC2 binding protein, 7B2. 7B2 deficiency did not mimick PC2 deficiency exactly in terms of proCCK processing. Hence, the changes in the processing of proCCK in cerebral tissue were less pronounced after 7B2 knockout (Tables 1 and 2) . Notably, the cerebral levels of proCCK and its products differed not only between the two kinds of knockout mice, but also between the corresponding wildtype controls. Presumably, this difference reflects that two different strains of mice were examined (the PC2 study used C57BL/6 J:Sv129 mice, and the 7B2 study Sv129 mice), and that the 7B2 knockout mice due to high mortality were Fig. 3 Gel chromatography on Sephadex G-50 superfine columns of neutral water extract from the brain of a PC2 knockout (KO) and a corresponding wild-type (WT) mouse. The chromatographic elution was monitored by radioimmunoassay using antibody number 3208 that binds glycineextended CCK-peptides (upper panels). Antibody number 3208 was also used after trypsin and carboxypeptidase B treatment of each fraction to indicate the elution of proCCK (lower panels).
considerably younger than the PC2 knockout mice. Thus, it is known that the cerebral maturation of proCCK processing first reach adult precursor-product ratios 1-3 months after birth in rats (Mogensen et al. 1990 (Mogensen et al. , 1991 . Therefore, the difference in strain and age probably explain the wild-type discrepancies in both cerebral and intestinal extracts.
In contrast with PC2, knockout of the 7B2 gene does in fact affect the processing of proCCK in the small intestine in terms of halving the concentrations of carboxyamidated CCK-peptides (Table 4) . This is surprising, because no effect could be measured in the PC2-null mice (Table 3) . The mechanism behind this 7B2 effect is unknown, but in line with the observation that 7B2-and PC2-null mice have different phenotypes (Furuta et al. 1997; Westphal et al. 1999) . The results of this study therefore supports the contention, that 7B2 in addition to its function as a molecular escort for PC2 might have other activities (Westphal et al. 1999; Rehfeld et al. 2002) . Such functions were suggested in earlier studies showing that 7B2-null animals hypersecrete ACTH from the intermediate lobe of the pituitary, while PC2-null animals do not (Westphal et al. 1999; Lindberg, unpublished results) . This role is unlikely to represent binding to other convertases, as no convertase other than PC2 was able to interact with 7B2 in coimmunoprecipitation experiments (Benjannet et al. 1995) . Proenkephalin is apparently similarly processed in PC2-and 7B2-null animals (Johanning et al. 1998; Westphal et al. 1999) . Proglucagon processing in both null models has been studied using pulsechase analysis (Westphal et al. 1999; Furuta et al. 2001) and has been shown to be slightly more extensive in the PC2 null than in the 7B2 null mice. Thus, the contribution of 7B2 (beyond the role of assisting PC2) to overall processing appears to vary by the structure of the precursor to be processed. Given the recent identification of a cellular binding protein for PC1, proSAAS (Fricker et al. 2000) , the differential contributions of convertase binding proteins to precursor processing is likely to represent a fruitful area for further study.
An effect of PC2 on CCK processing has been reported recently in cell lines (Wang and Beinfeld 1997; Yoon and Beinfeld 1997) and knockout mice (Vishnuvardhan et al. 2000) . These data resemble the present results on carboxyamidated CCK peptides, as Vishnuvardhan et al. also measured a slightly decreased concentration of CCK-8 in Fig. 4 Gel chromatography on a Sephadex G-50 superfine column of an acetic acid extract from the brain of a PC2 knockout mouse. The low concentrations of CCK peptides in acidic extracts of brains from wild-type mice prevented meaningful chromatography of controls. cerebral extracts from PC2-null mice. Otherwise, however, it is difficult to compare the studies, because the earlier studies (Wang and Beinfeld 1997; Yoon and Beinfeld 1997; Vishnuvardhan et al. 2000) used a single RIA that recognizes only amidated CCK peptides and at the same time binds gastrin peptides. Hence, Beinfeld and co-workers did not measure proCCK and its processing intermediates, which as shown in this study, are parameters heavily affected in PC2 deficiency. Moreover, the concentrations of cerebral proCCK and its processing-intermediates are affected in a direction opposite of those of the amidated CCKs. 
